141 related articles for article (PubMed ID: 32726924)
1. Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome.
Parks RM; Albanghali M; Syed BM; Green AR; Ellis IO; Cheung KL
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726924
[TBL] [Abstract][Full Text] [Related]
2. Patterns of biomarker expression in patients treated with primary endocrine therapy - a unique insight using core needle biopsy tissue microarray.
Parks RM; Albanghali MA; Syed BM; Green AR; Ellis IO; Cheung KL
Breast Cancer Res Treat; 2021 Feb; 185(3):647-655. PubMed ID: 33226492
[TBL] [Abstract][Full Text] [Related]
3. Liver Kinase B1-A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older Women.
Syed BM; Green AR; Morgan DAL; Ellis IO; Cheung KL
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30696074
[No Abstract] [Full Text] [Related]
4. Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts.
Syed BM; Green AR; Paish EC; Soria D; Garibaldi J; Morgan L; Morgan DA; Ellis IO; Cheung KL
Br J Cancer; 2013 Mar; 108(5):1042-51. PubMed ID: 23462719
[TBL] [Abstract][Full Text] [Related]
5. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.
Asogan AB; Hong GS; Arni Prabhakaran SK
Singapore Med J; 2017 Mar; 58(3):145-149. PubMed ID: 27029805
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
Chen X; Yuan Y; Gu Z; Shen K
Breast Cancer Res Treat; 2012 Aug; 134(3):957-67. PubMed ID: 22370627
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
Syed BM; Morgan D; Setty T; Green AR; Paish EC; Ellis IO; Cheung KL
PLoS One; 2017; 12(12):e0188528. PubMed ID: 29284000
[TBL] [Abstract][Full Text] [Related]
8. Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer?
Al Sarakbi W; Salhab M; Thomas V; Mokbel K
Int Semin Surg Oncol; 2005 Aug; 2():15. PubMed ID: 16115314
[TBL] [Abstract][Full Text] [Related]
9. Concordance between core needle biopsy and surgical excision specimens for Ki-67 in breast cancer - a systematic review of the literature.
Kalvala J; Parks RM; Green AR; Cheung KL
Histopathology; 2022 Feb; 80(3):468-484. PubMed ID: 34473381
[TBL] [Abstract][Full Text] [Related]
10. Age-Related Biology of Early-Stage Operable Breast Cancer and Its Impact on Clinical Outcome.
Syed BM; Green AR; Rakha EA; Morgan DAL; Ellis IO; Cheung KL
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808856
[TBL] [Abstract][Full Text] [Related]
11. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.
Nakamura R; Yamamoto N; Shiina N; Miyaki T; Ikebe D; Itami M; Shida T; Miyazaki M
Breast; 2016 Apr; 26():141-7. PubMed ID: 26732051
[TBL] [Abstract][Full Text] [Related]
12. Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients.
Chen X; Zhu S; Fei X; Garfield DH; Wu J; Huang O; Li Y; Zhu L; He J; Chen W; Jin X; Shen K
BMC Cancer; 2015 Oct; 15():822. PubMed ID: 26514283
[TBL] [Abstract][Full Text] [Related]
13. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
14. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
[TBL] [Abstract][Full Text] [Related]
15. How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer.
Saghir H; Veerla S; Malmberg M; Rydén L; Ehinger A; Saal LH; Vallon-Christersson J; Borg Å; Hegardt C; Larsson C; Haidar A; Hedenfalk I; Loman N; Kimbung S
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010992
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer.
Jeong YS; Kang J; Lee J; Yoo TK; Kim SH; Lee A
J Pathol Transl Med; 2020 Jan; 54(1):87-94. PubMed ID: 31718121
[TBL] [Abstract][Full Text] [Related]
17. Core needle biopsy as an alternative to whole section in IHC4 score assessment for breast cancer prognostication.
Liu M; Tang SX; Tsang JYS; Shi YJ; Ni YB; Law BKB; Tse GMK
J Clin Pathol; 2018 Dec; 71(12):1084-1089. PubMed ID: 30228212
[TBL] [Abstract][Full Text] [Related]
18. Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer.
Xie L; Li X; Wang Q; Zhou J; Shen J; Luo L; Lu Y; Wang L
Onco Targets Ther; 2018; 11():677-685. PubMed ID: 29440915
[TBL] [Abstract][Full Text] [Related]
19. Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?
Puccetti M; Ravaioli S; Tumedei MM; Bucchi E; Malmesi M; Medri L; Bravaccini S
Histopathology; 2018 Nov; 73(5):801-808. PubMed ID: 29944734
[TBL] [Abstract][Full Text] [Related]
20. Biology of primary breast cancer in older women beyond routine biomarkers.
Parks RM; Alfarsi LH; Green AR; Cheung KL
Breast Cancer; 2021 Sep; 28(5):991-1001. PubMed ID: 34165702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
